Autosomal recessive Parkinson disease 14
MONDO:0013060A rare neurodegenerative disease usually presenting before the age of 30 and which is characterized by dystonia, L-dopa-responsive parkinsonism, pyramidal signs and rapid cognitive decline.
Also known as: PARK14, PLA2G6 hereditary late onset Parkinson disease, PLA2G6-related dystonia-parkinsonism, autosomal recessive Parkinson disease type 14, dystonia-parkinsonism, Paisan-Ruiz type, hereditary late onset Parkinson disease caused by mutation in PLA2G6, Parkinson disease 14, autosomal recessive, adult-onset dystonia - parkinsonism
25 clinical trials for this condition and its sub-types.
Follow this condition to get notified about new trialsBroader categories
-
Could stem cells ease Parkinson's symptoms? new trial launches
Disease control Not yet recruitingThis study tests two types of stem cell treatments for people with Parkinsonism, a condition that causes movement and non-movement problems. The goal is to see if these treatments are safe and can improve symptoms like tremors, stiffness, and mood changes. About 120 adults aged 4…
Phase 2 • Sponsor: Biocells Medical • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Could zapping the spine steady blood pressure in Parkinson's?
Disease control Not yet recruitingThis study tests whether spinal cord stimulation can help people with Parkinson's disease who experience sudden drops in blood pressure when standing up. Forty participants will receive either an implanted stimulator or a non-invasive version. The goal is to see if the treatment …
Sponsor: Ruijin Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC